Complement and Kidney Disease
DOI: 10.1007/3-7643-7428-4_10
|View full text |Cite
|
Sign up to set email alerts
|

Complement defects in children which result in kidney diseases: diagnosis and therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
1
0
1

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 112 publications
1
1
0
1
Order By: Relevance
“…The similar change were observed in kidney [35,36]. In glomerulonephritis, subendothelial complement deposits [36,37] and sun epithelial (similar to situation in thyroid) immunoglobulins deposits [35,36] were observed. In Hashimoto's thyroiditis, the plasma cells were polarized and formed the microtubule organizing center (MTOC) consisting of centrioles, mitochondria and Golgi apparatus and probably microtubules and microfilaments.…”
Section: Discussionsupporting
confidence: 75%
“…The similar change were observed in kidney [35,36]. In glomerulonephritis, subendothelial complement deposits [36,37] and sun epithelial (similar to situation in thyroid) immunoglobulins deposits [35,36] were observed. In Hashimoto's thyroiditis, the plasma cells were polarized and formed the microtubule organizing center (MTOC) consisting of centrioles, mitochondria and Golgi apparatus and probably microtubules and microfilaments.…”
Section: Discussionsupporting
confidence: 75%
“…Podobne zmiany były obserwowane przez innych badaczy w zapaleniu kłębków nerkowych [35,36]. W glomerulonephritis obserwowano podśródbłonkowe depozyty dopełniacza [36,37] i podnabłonkowe (podobnie jak w tarczycy) depozyty immunoglobulin [35,36].…”
Section: Dyskusjaunclassified
“…Based on the evidence that the defective complement system is associated with HUS, as well as the frequency of the reported genetic mutations, a diagnostic algorithm was recently proposed [36]. As diagnosis can be rather expensive the rationale for analysis is presented as a hierarchical order: 1. check for complement activation in serum, in terms of APH50, CH50, decreased C3b levels and the appearance of C3 degradation products C3d; 2. analyse expression levels and mobility of the central regulator factor H by enzyme-linked immunosorbent assay (ELISA) or Western blotting, respectively; 3. if C-activation exists, but normal levels and mobility are observed, genetic analyses should be initiated by analyzing the factor H gene 4. if factor H appears normal additional complement regulators like factor I and MCP should be tested.…”
Section: Diagnostic Algorithmmentioning
confidence: 99%